Showing results (151-160 of 170) with videos related to

Sort By:
Pageof 17
Medicine|October 3, 2019
Underlying nonalcoholic fatty liver disease is a significant factor for breast cancer recurrence after curative surgeryYoung-Sun Lee, Ha Seok Lee, Sung Won Chang, et al.
Cancer Cell|May 18, 2011
Radiation acts on the microenvironment to affect breast carcinogenesis by distinct mechanisms that decrease cancer latency and affect tumor typeDavid H Nguyen, Hellen A Oketch-Rabah, Irineu Illa-Bochaca, et al.
The American Journal of Pathology|January 30, 2010
Pathways contributing to development of spontaneous mammary tumors in BALB/c-Trp53+/- miceHaoheng Yan, Anneke C Blackburn, S Christine McLary, et al.
Cancer Chemotherapy and Pharmacology|July 29, 2005
Phase II study with a combination of epirubicin, cisplatin, UFT, and leucovorin in advanced hepatocellular carcinomaSeok Jin Kim, Hee Yun Seo, Jong Gwon Choi, et al.
Thoracic Cancer|April 5, 2016
Safety and efficacy of single-agent docetaxel (Taxotere) administered weekly in non-small cell lung carcinoma patients in Korea: An observational studySun Min Lim, Byeong Bae Park, Keun-Chil Park, et al.
JAMA Oncology|October 25, 2019
Efficacy, Safety, and Tolerability of Pertuzumab, Trastuzumab, and Docetaxel for Patients With Early or Locally Advanced ERBB2-Positive Breast Cancer in Asia: The PEONY Phase 3 Randomized Clinical TrialZhimin Shao, Da Pang, Hongjian Yang, et al.
Cancer Chemotherapy and Pharmacology|February 2, 2013
Combination of gemcitabine and carboplatin as first line treatment in elderly patients or those unfit for cisplatin-based chemotherapy with advanced transitional cell carcinoma of the urinary tractJoo Hee Park, Soon Wook Lee, Hye Sook Kim, et al.
Leukemia Research|September 19, 2009
The suggestion of a risk stratification system for febrile neutropenia in patients with hematologic diseaseYong Park, Dae Sik Kim, Seh Jong Park, et al.
Human Mutation|September 15, 2004
BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancerJae Hong Seo, Dae-Yeon Cho, Se-Hyun Ahn, et al.
Oncogene|May 2, 2022
A novel HSP90 inhibitor SL-145 suppresses metastatic triple-negative breast cancer without triggering the heat shock responseJi Young Kim, Tae-Min Cho, Jung Min Park, et al.
Pageof 17